You are here

BioAge Labs

After an obesity stumble, BioAge reconnects with its longevity pipeline

Pharma Voice

Wed, 01/22/25 - 11:20 am

BioAge Labs aims to raise $180M from IPO, private placement to fund obesity trials

Fierce Biotech

Wed, 09/25/24 - 11:48 am

BioAge files for IPO, plans pair of midstage obesity trials

Fierce Biotech

Wed, 09/4/24 - 11:40 am

clinical trials

Eli Lilly partner BioAge raises $170 mln for obesity treatment

Reuters

Tue, 02/13/24 - 11:24 am

Lilly to help BioAge test muscle regeneration therapy in combo with weight loss drug tirzepatide

Fierce Biotech

Thu, 10/26/23 - 10:46 pm

muscle regeneration

Biogen, BioAge and PTC Present Novel MoAs in Neurodegenerative Diseases

BioSpace

Mon, 11/7/22 - 10:52 am

neurodegenerative disease

PTC Therapeutics

Anti-aging biotech upstart plucks a drug from Amgen's discard pile, pivoting from heart failure to muscle conditions

Endpoints

Wed, 04/14/21 - 09:24 am